CRNT
Ceragon Networks Ltd.
NasdaqGSUSDEQUITY
Technology
DELAYED
Last price
2.10
▼ 0.02 (0.72%)
MARKET · —
Price
Open
2.05
Prev close
2.12
Day high
2.14
Day low
2.08
Volume
198.54K
Market cap
$190.78M
P/E (TTM)
—
52W range
1.85 – 3.29
Trailing performance
Returnvs SPY
1W
-5.00%
-3.6%
1M
-5.86%
-9.6%
3M
-17.39%
-20.5%
6M
-9.13%
-20.2%
YTD
-0.48%
-12.8%
1Y
+11.17%
-8.8%
3Y
+11.17%
-63.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$190.78M
Enterprise value$184.27M
Revenue (TTM)$346.73M
Gross profit$116.82M
EBITDA$23.81M
Net income$-3.28M
EPS (TTM)$-0.03
Free cash flow$28.34M
Total cash$34.77M
Total debt$28.78M
Book value / share$1.89
Shares outstanding91.28M
Float79.49M
Short % of float0.75%
Dividend yield—
Beta (5Y)1.37
Valuation & profitability ratios
Trailing P/E—
Forward P/E11.74
PEG ratio0.98
Price / sales—
Price / book1.11
EV / revenue0.53
EV / EBITDA7.74
Gross margin33.69%
Operating margin1.69%
Profit margin-0.95%
Return on equity-1.91%
Return on assets1.86%
Debt / equity16.73
Current ratio1.85
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total revenue | $338.73M | $394.19M | $347.18M | $295.17M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | -$2.09M | $24.06M | $6.22M | -$7.40M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$2.09M | $24.06M | $6.22M | -$7.40M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.00 | 0.02 | +400.0% |
| Dec 2025 | 0.02 | 0.02 | 0.0% |
| Sep 2025 | 0.02 | 0.00 | -100.0% |
| Jun 2025 | 0.03 | 0.03 | -7.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.00 | 5 | $86.45M | +5.1% |
| Next quarter | 0.04 | 5 | $96.17M | +16.8% |
| Current year | 0.10 | 5 | $369.49M | +9.1% |
| Next year | 0.18 | 5 | $393.15M | +6.4% |
Analyst targets & ownership
Mean target$4.83
High target$9.00
Low target$3.00
Implied upside130.19%
Analyst count6
ConsensusSTRONG BUY
Strong buy / Buy1 / 5
Hold0
Sell / Strong sell0 / 0
Held by insiders14.12%
Held by institutions23.16%
Institutions holding93
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
+270.17K
Net buying
Buy transactions
12
281.83K shares
Sell transactions
2
11.67K shares
Net transactions
+14
Buys less sells
Sell : buy shares
0.0 : 1
Mixed
Insider-held shares
12.85M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Jun 12, 26 | MAKOV EFRAT Director |
SELL | 5.00K | $14.97K | Direct |
| Jun 12, 26 | MAKOV EFRAT Director |
CONVERSION | 5.00K | $9.95K | Direct |
| Jun 11, 26 | ARAZI DORON Chief Executive Officer |
STOCK | 66.67K | $0 | Direct |
| May 22, 26 | MAKOV EFRAT Director |
SELL | 6.67K | $17.67K | Direct |
| May 22, 26 | MAKOV EFRAT Director |
CONVERSION | 6.67K | $14.05K | Direct |
| May 22, 26 | WADSWORTH ROBERT M Director |
STOCK | 20.63K | $0 | Direct |
| May 22, 26 | RIPSTEIN DAVID Director |
STOCK | 21.27K | $0 | Direct |
| May 22, 26 | HADAR RAMI Director |
STOCK | 21.27K | $0 | Direct |
| May 22, 26 | ROSEN ILAN Director |
STOCK | 31.89K | $0 | Direct |
| May 22, 26 | MAKOV EFRAT Director |
STOCK | 21.27K | $0 | Direct |
| May 22, 26 | SHLOMO LIRAN Director |
STOCK | 21.27K | $0 | Direct |
| May 22, 26 | SHAHAM YAEL Director |
STOCK | 21.27K | $0 | Direct |
| Mar 23, 26 | STEIN RONEN Chief Financial Officer |
STOCK | 17.42K | $0 | Direct |
| Mar 23, 26 | RONEN BEN-HAMOU Officer |
STOCK | 27.21K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ARAZI DORON |
Chief Executive Officer | 375.00K | Stock Award(Grant) |
HADAR RAMI |
Director | 58.95K | Stock Award(Grant) |
MAKOV EFRAT |
Director | 58.95K | Sale |
RIPSTEIN DAVID |
Director | 46.76K | Stock Award(Grant) |
RONEN BEN-HAMOU |
Officer | 109.44K | Stock Award(Grant) |
ROSEN ILAN |
Director | 93.39K | Stock Award(Grant) |
SHAHAM YAEL |
Director | 58.95K | Stock Award(Grant) |
SHLOMO LIRAN |
Director | 58.95K | Stock Award(Grant) |
STEIN RONEN |
Chief Financial Officer | 87.52K | Stock Award(Grant) |
WADSWORTH ROBERT M |
Director | 51.01K | Stock Award(Grant) |
Moving averages & technicals
SMA 10
2.15
-2.29% from price
SMA 20
2.17
-3.62% from price
SMA 50
2.34
-10.86% from price
SMA 100
2.47
-14.89% from price
SMA 200
2.33
-10.40% from price
EMA 12
2.15
-2.35% from price
EMA 26
2.21
-4.83% from price
EMA 50
2.30
-8.67% from price
RSI (14)
39.9
Neutral
MACD (12,26,9)
-0.06
Hist 0.00
ATR (14)
0.09
4.31% of price
Realised vol 30D
45.9%
Annualised
Bollinger upper
2.28
20, 2σ
Bollinger lower
2.06
20, 2σ
50 / 200 cross
Golden
2.34 vs 2.33
Trend bias
Below 200
-10.40%
Risk profile
Beta vs SPY
2.04
More volatile than market
Correlation to SPY
0.52
Loosely linked
Realised vol 30D
45.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-35.3%
Peak to trough
Max drawdown 5Y
-66.4%
Peak to trough
ATR 14
0.09
4.31% of price
Beta (reported)
1.37
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.02
Call-heavy session
Put / call open interest
0.00
Positioning, not flow
Max pain
2.00
-4.3% from spot
ATM implied vol
67.2%
Nearest strike to spot
Skew (10% OTM)
-16.4%
Calls bid over puts
Call volume
350
Contracts, this expiry
Put volume
6
Contracts, this expiry
Heaviest call OI
3.00
1.77K contracts
Heaviest put OI
2.00
12 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
MoneyMasters Podcast 8-20-26- Canadian Commodity Plays or American AI Stocks
MoneyShow · 2d ago
Ceragon (CRNT) Q2 2026 Earnings Call Transcript
Motley Fool · 3d ago
Ceragon Networks Ltd (CRNT) (Q2 2026) Earnings Call Highlights: Record Bookings and Strategic ...
GuruFocus.com · 11d ago
Ceragon Networks Ltd. Q2 2026 Earnings Call Summary
Moby · 11d ago
Ceragon Networks Q2 Earnings Call Highlights
MarketBeat · 11d ago
Ceragon shares gain 4% after second-quarter earnings beat
InvestorsHub · 11d ago
Ceragon: Q2 Earnings Snapshot
Associated Press · 11d ago
Ceragon Reports 2026 Second Quarter Financial Results
PR Newswire · 11d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.